K-C HEMOSTATIC BIOPSY SYSTEM— 510(k) K050135

Substantially Equivalent

Bioengineering Consultants , Ltd.

FDA 510(k) clearance K050135 for K-C HEMOSTATIC BIOPSY SYSTEM, Substantially Equivalent on 2005-07-13. Applicant: Bioengineering Consultants , Ltd..

Clearance details

Applicant: Bioengineering Consultants , Ltd.
Product code: Code FCG
Advisory panel: Gastroenterology, Urology
Date received: 2005-01-21
Decision date: 2005-07-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Charlottesville, VA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code FCG

product code FCG

Death: 13
Injury: 576
Malfunction: 1,966
Total: 2,555

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.